Edity Therapeutics Alternatives & Competitors

12 companies similar to Edity Therapeutics — Using human immune cells to deliver therapeutic proteins

Immusoft

Cell therapy company dedicated to improving the lives of patients with rare diseases

22 Grant $49.27M

Seattle, United States

Biotechnology Health Care +2

Vesigen Therapeutics, Inc.

Delivering intracellular therapeutics with ARMMed microvesicles

19 Grant $28.50M

Cambridge, United States

Biotechnology Health and Wellness

Harpoon Therapeutics

SPEARHEADING IMMUNOTHERAPIES

33 Post-IPO Equity $255.00M

South San Francisco, Unit...

Biotechnology Health Care +1

Compare

Granza Bio

Reprogramming Immunity for Target-Specific Medicines

7 Seed $7.64M

Biopharma Biotechnology +1

Track all Edity Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Kelonia Therapeutics

Revolutionizing in vivo gene delivery to usher in a new era of genetic medicines.

74 Private Equity $3.30B

Boston, United States

Biotechnology Health Care +1

GenEdit

Delivering the potential of genetic medicines

47 Series A $67.73M

South San Francisco, Unit...

Biotechnology Health and Wellness +1

Repertoire Immune Medicines

Repertoire is a biotechnology company creating a new category of immune medicines for canc...

86 Series B $189.00M

Cambridge, United States

Biotechnology Health and Wellness +1

Anocca

Engineered Immunity

122 Venture round $472.00M

Sodertalje, Sweden

Biotechnology Health Care +1

TransCode Therapeutics, Inc.

Delivering a cancer-free future

11 Post-IPO Equity $28.05M

Newton, United States

Biotechnology Health Care +1

Scarlet Therapeutics Ltd

We believe the future of medicine is in our blood.

13 Seed

Bristol, United Kingdom

Biotechnology Health and Wellness

Altheia Science

Altheia Science develops treatments for autoimmune diseases and cancer using innovative to...

6 Series A $11.00M

Milano, Italy

Biotechnology Health Care +1

Cell BioEngines, Inc

‘Off-the-Shelf’ Curative Cell Therapies

3 Pre-Seed $1.38M

New York, United States

Biotechnology Health and Wellness

About Edity Therapeutics

Edity Therapeutics, established in 2020, is a biotechnology startup hailing from Israel that is making waves with its pioneering approach to using human immune cells for delivering therapeutic proteins. The company's platform offers a revolutionary way to transfer these proteins to the target cells of patients, enablin...

Business keywords

Gene Editing, Cell Therapy, Immune Cells, Therapeutic Proteins, Drug Delivery, In-vivo Gene Editing, T-cells, Cancer, Intracellular Pathways, Target Cells, Enzyme Therapy, Immunotherapy, Innovation, Startup

Frequently Asked Questions

Companies similar to Edity Therapeutics include Immusoft, Vesigen Therapeutics, Inc., Harpoon Therapeutics, Granza Bio, Kelonia Therapeutics. They work in Biotechnology and Health and Wellness and share Edity Therapeutics 's focus on cell therapy, immunotherapy and gene editing.

Bounce Watch lists 12 companies that share Edity Therapeutics 's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Edity Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Edity Therapeutics Profile Immusoft Alternatives Vesigen Therapeutics, Inc. Alternatives Harpoon Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Edity Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.